Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2020

01-12-2020 | Mood Disorders | Case report

Eltrombopag/immune globulin/methylprednisolone

Depression and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Azizoglu M, et al. Eltrombopag therapy in pediatric acute and chronic immune thrombocytopenia. Research and Practice in Thrombosis and Haemostasis 4 (Suppl. 1): 694-695 (plus poster) abstr. PB1355, Jul 2020. Available from: URL: http://​doi.​org/​10.​1002/​rth2.​12393 [abstract]
Metadata
Title
Eltrombopag/immune globulin/methylprednisolone
Depression and lack of efficacy: case report
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-87594-7

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Clinical study

Thromboembolic or bleeding events with DOACs and AEDs

Case report

Doxorubicin-liposomal/trabectedin

Case report

Olodaterol/tiotropium-bromide

Case report

Immunosuppressants

Case report

Azathioprine/methylprednisolone/prednisolone

Case report

Naproxen